Organon & Co. OGN
$13.43
▼ -0.07% 24H
About
Organon & Co. is a science-based global pharmaceutical company that develops and delivers innovative health solutions through a portfolio of prescription therapies. Its primary focus areas include women’s health, biosimilars, and established brands, addressing key therapeutic needs in reproductive health, dermatology, …
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - General
CountryUnited States
Employees10,000
TickerOGN
Statistics
Market Cap$3.53B
Revenue (TTM)$6.22B
Net Income$187.0M
Net Margin3.0%
EPS$0.93
P/E14.39
P/S0.57
P/B3.89
EV/EBITDA6.88
ROE34.0%
Dividend Yield0.59%
Price$13.43
Data: Twelve Data · Revenue = mcap / P/S